Epidemiologic classification of human papillomavirus types associated with cervical cancer, The New England journal of medicine.N.Engl.J.Med, vol.3486, pp.518-545, 2003. ,
??pid??miologie et histoire naturelle de l???infection g??nitale ?? papillomavirus humain, Gyn??cologie Obst??trique & Fertilit??, vol.30, issue.2, pp.139-146, 2002. ,
DOI : 10.1016/S1297-9589(01)00282-X
Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study, International Journal of Cancer, vol.367, issue.Suppl 3, pp.428-432, 2008. ,
DOI : 10.1002/ijc.23092
Against which human papillomavirus types shall we vaccinate and screen? the international perspective, International Journal of Cancer, vol.183, issue.2, pp.278-285, 202004. ,
DOI : 10.1002/ijc.20244
Global Burden of Human Papillomavirus and Related Diseases, Vaccine, vol.30, 2012. ,
DOI : 10.1016/j.vaccine.2012.07.055
Epidemiologie des infections génitales à papillomavirus. La revue du patricien, Nov, vol.15, pp.1857-1881, 2006. ,
Données épidémiologiques sur le cancer du col de l'utérus ; Etat des connaissances. Actualisation, 2008. ,
Cancer incidence, Moratilty and Prevalence worldwide. IARC CancerBase N5 version 2, 2002. ,
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data, The Lancet Infectious Diseases, vol.11, issue.1, pp.39-44, 2011. ,
DOI : 10.1016/S1473-3099(10)70225-5
HPV vaccination in France: Uptake, costs and issues for the National Health Insurance, Vaccine, vol.29, issue.19, pp.3610-3616, 2011. ,
DOI : 10.1016/j.vaccine.2011.02.064
HPV vaccine and cervical cancer prevention in general practice Survey conducted among general practitioners in the French departments of Eure-et-Loire and Cher, Rev.Prat, vol.58, pp.25-31, 2008. ,
Opinions et pratiques des m??decins g??n??ralistes face ?? la vaccination anti-Papillomavirus, M??decine et Maladies Infectieuses, vol.39, issue.10, pp.789-97, 2009. ,
DOI : 10.1016/j.medmal.2009.08.007
Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing, Vaccine, vol.29, issue.32, pp.5322-5330, 2011. ,
DOI : 10.1016/j.vaccine.2011.05.006
URL : https://hal.archives-ouvertes.fr/hal-00698034
Vaccination : perceptions et attitudes, Connaissances, attitudes et comportements face au risque infectieux. Saint-Denis : Inpes, pp.89-101, 2006. ,
Vacciner contre l'hépatite B ? Ce qu'en disent des parents et des médecins de l'agglomération stéphanoise, Medicine, vol.7, pp.333-340, 2011. ,
???MMR talk??? and vaccination choices: An ethnographic study in Brighton, Social Science & Medicine, vol.61, issue.3, pp.709-728, 2005. ,
DOI : 10.1016/j.socscimed.2004.12.014
Qualitative Analysis of Mothers' Decision-Making About Vaccines for Infants: The Importance of Trust, PEDIATRICS, vol.117, issue.5, pp.1532-1573, 2006. ,
DOI : 10.1542/peds.2005-1728
Que pensent les parents de la vaccination? Une étude qualitative ,
Lay epidemiology and the prevention paradox : the implications of coronary candidacy for health education, Sociology of Health & Illness, vol.13, 1991. ,
Enquête sur la sexualité en France, 2008. ,
La sexualité des jeunes Québécois et Canadiens ,
Use of emergency contraceptive pill by 15-year-old girls: results from the international Health Behaviour in School-aged Children (HBSC) study, BJOG: An International Journal of Obstetrics & Gynaecology, vol.108, issue.1, pp.1197-1204, 2010. ,
DOI : 10.1111/j.1471-0528.2010.02637.x
URL : https://hal.archives-ouvertes.fr/inserm-00506135
Sexual behaviour in Britain: early heterosexual experience, The Lancet, vol.358, issue.9296, pp.1843-1850, 2001. ,
DOI : 10.1016/S0140-6736(01)06885-4
Relations sexuelles précoces Rapport sur la santé, Statistiques Canada, vol.16, issue.3, pp.11-21, 2005. ,
How Well-protected are Sexually Active 15-year Olds? Cross-national Patterns in Condom and Contraceptive Pill Use, International Journal of Public Health, vol.54, issue.2, pp.1-7, 2002. ,
HPV vaccine and cervical cancer prevention in general practice.Survey conducted among general practitioners in the French departments of Eure-et-Loir and Cher, Rev.Prat, vol.58, pp.25-31, 2008. ,
Opinions et pratiques des m??decins g??n??ralistes face ?? la vaccination anti-Papillomavirus, M??decine et Maladies Infectieuses, vol.39, issue.10, pp.789-97, 2009. ,
DOI : 10.1016/j.medmal.2009.08.007
Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing, Vaccine, vol.29, issue.32, pp.5322-5330, 2011. ,
DOI : 10.1016/j.vaccine.2011.05.006
URL : https://hal.archives-ouvertes.fr/hal-00698034
Danger et risques des vaccins: mythes et réalités « La pharmacovigilance des vaccins ». Adsp n°71 juin, pp.37-39, 2010. ,
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. Accepted for publication, J Intern Med, 2013. ,
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine, Journal of Internal Medicine, vol.302, issue.2, pp.193-203, 2012. ,
DOI : 10.1111/j.1365-2796.2011.02467.x
De l'obligation vaccinale à la recommandation. ADSP n°71 juin, pp.16-18, 2010. ,
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data, The Lancet Infectious Diseases, vol.11, issue.1, pp.39-44, 2011. ,
DOI : 10.1016/S1473-3099(10)70225-5
The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme, Sexually Transmitted Infections, vol.87, issue.7, pp.10-1136, 2011. ,
DOI : 10.1136/sextrans-2011-050234
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study, The Lancet, vol.377, issue.9783, pp.2085-92, 2011. ,
DOI : 10.1016/S0140-6736(11)60551-5
Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium), Vaccine, vol.29, issue.46, 2011. ,
DOI : 10.1016/j.vaccine.2011.08.039
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study, The Lancet, vol.384, issue.9961, pp.140-673660920, 2014. ,
DOI : 10.1016/S0140-6736(14)60920-X
HPV vaccination: for women of all ages ? Lancet, 2014; publication avancée en ligne le 2 septembre. Doi:.10, pp.140-673661230, 1016. ,